Skip to main content

Motorola, Compugen In DNA Chip Venture

  • Author:
  • Publish date:

Motorola

(MOT)

and Israeli biotechnology firm

Compugen

(CGEN) - Get Compugen Ltd. Report

said Tusday they have signed an agreement to jointly develop, manufacture and commercialize selected DNA biochips.

Scroll to Continue

TheStreet Recommends

The companies did not disclose financial terms of the deal, but said Motorola's biochip systems unit will use Compugen's LEADS platform and proprietary DNA chip-design tools, which improve scientists' ability to incorporate the biologically active variant of genes into the design and manufacture the DNA biochips.

Shares of Compugen were recently up 5%, or 38 cents, to $8 in trading on the

Nasdaq

, while Motorola shares fell 1.44%, or 31 cents, to $21.38 on the

New York Stock Exchange

composite trading.